Fosun files Club Med HK IPO as resort revenue rises 0.2%

Fosun International filed a Hong Kong listing application for Club Med Holding, which posted EUR1.083 billion in interim revenue, up 0.2 percent year over year.

The preliminary prospectus shows the all-inclusive resort operator's profit fell 12.3 percent to EUR57.125 million for the six months ended June 2026. Adjusted EBITDA under non-IFRS declined 2.9 percent to EUR266 million.

Fosun International (00656.HK) shares rose 0.924 percent, with short selling of HK$10.68 million representing 16.478 percent of turnover. The parent reported first-half 2026 net profit of RMB1.721 billion, up 1.6 times year over year.

The spin-off would give Club Med Holding a standalone Main Board listing on the Hong Kong Stock Exchange, separating the resort brand from Fosun's broader conglomerate portfolio. The application does not yet disclose offer price, deal size, or listing timeline.

Club Med, acquired by Fosun in 2015, operates all-inclusive resorts across Europe, Asia, the Americas, and Africa. The brand has been a core asset in Fosun's tourism and consumer segment, which the conglomerate has positioned as a key growth driver alongside its financial and healthcare businesses.

The listing application follows Fosun's broader strategy of unlocking value from portfolio companies through separate listings as the conglomerate seeks to streamline operations and reduce leverage. Fosun has previously pursued similar spin-off structures for other subsidiaries in its portfolio.

The filing adds to a pipeline of consumer and travel-related listings seeking a Hong Kong exchange debut. Club Med's global footprint and brand recognition could draw institutional interest from investors seeking exposure to the travel and leisure sector.

Offer price, cornerstone investors, and lead underwriters have not yet been disclosed. The company will need approval from the Securities and Futures Commission before proceeding with the listing.

The spin-off gives Club Med Holding a direct equity valuation separate from Fosun's conglomerate discount. Investors will watch the prospectus update for pricing details and the listing timeline.

This article is for informational purposes only and does not constitute investment advice.